- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/745 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class C07K 14/745
Total number of patents in this class: 695
10-year publication summary
|
51
|
60
|
60
|
56
|
58
|
28
|
33
|
27
|
28
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2715 |
22 |
| Modernatx, Inc. | 1291 |
18 |
| Bioverativ Therapeutics Inc. | 211 |
16 |
| The Children's Hospital of Philadelphia | 857 |
15 |
| Opko Biologics Ltd. | 78 |
13 |
| Yale University | 2527 |
12 |
| Immunitybio, Inc. | 507 |
12 |
| The University of North Carolina at Chapel Hill | 2093 |
11 |
| CSL Limited | 246 |
10 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 297 |
10 |
| CSL Behring GmbH | 346 |
9 |
| Case Western Reserve University | 1888 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3337 |
8 |
| Octapharma AG | 200 |
8 |
| Gladiator Biosciences, Inc. | 10 |
8 |
| Amunix Pharmaceuticals, Inc. | 89 |
8 |
| Affibody AB | 113 |
7 |
| Alexion Pharmaceuticals, Inc. | 648 |
7 |
| Xencor, Inc. | 412 |
7 |
| Cytiva BioProcess R&D AB | 322 |
7 |
| Other owners | 479 |